Publications en collaboration avec des chercheurs de Fundación Jiménez Díaz (22)

2023

  1. DLL3 Is a Prognostic and Potentially Predictive Biomarker for Immunotherapy Linked to PD/PD-L Axis and NOTCH1 in Pancreatic Cancer

    Biomedicines, Vol. 11, Núm. 10

2021

  1. A DNA damage repair gene-associated signature predicts responses of patients with advanced soft-tissue sarcoma to treatment with trabectedin

    Molecular Oncology, Vol. 15, Núm. 12, pp. 3691-3705

  2. Aryl hydrocarbon receptor interacting protein (AIP) significantly influences prognosis of pancreatic carcinoma

    Annals of Diagnostic Pathology, Vol. 53

2020

  1. The clinical significance of PIWIL3 and PIWIL4 expression in pancreatic cancer

    Journal of Clinical Medicine, Vol. 9, Núm. 5

2019

  1. The prognosis value of PIWIL1 and PIWIL2 expression in pancreatic cancer

    Journal of Clinical Medicine, Vol. 8, Núm. 9

2018

  1. Prognostic factors in adenocarcinoma of the ampulla of Vater

    Revista Espanola de Patologia, Vol. 51, Núm. 4, pp. 210-215

2009

  1. Leukotriene B4 enhances the activity of nuclear factor-κB pathway through BLT1 and BLT2 receptors in atherosclerosis

    Cardiovascular Research, Vol. 81, Núm. 1, pp. 216-225

2008

  1. Chronic arthritis aggravates vascular lesions in rabbits with atherosclerosis: A novel model of atherosclerosis associated with chronic inflammation

    Arthritis and Rheumatism, Vol. 58, Núm. 9, pp. 2723-2734

  2. Effect of chondroitin sulphate in a rabbit model of atherosclerosis aggravated by chronic arthritis

    British Journal of Pharmacology, Vol. 154, Núm. 4, pp. 843-851

  3. Treatment with amlodipine and atorvastatin has additive effect on blood and plaque inflammation in hypertensive patients with carotid atherosclerosis

    Kidney International

2007

  1. Licofelone, a balanced inhibitor of cyclooxygenase and 5-lipoxygenase, reduces inflammation in a rabbit model of atherosclerosis

    Journal of Pharmacology and Experimental Therapeutics, Vol. 320, Núm. 1, pp. 108-116

2006

  1. Atorvastatin reduces the expression of prostaglandin E2 receptors in human carotid atherosclerotic plaques and monocytic cells: Potential implications for plaque stabilization

    Journal of Cardiovascular Pharmacology, Vol. 47, Núm. 1, pp. 60-69

  2. Fn14 is upregulated in cytokine-stimulated vascular smooth muscle cells and is expressed in human carotid atherosclerotic plaques: Modulation by atorvastatin

    Stroke, Vol. 37, Núm. 8, pp. 2044-2053

  3. Overexpression of COX-2, Prostaglandin E Synthase-1 and Prostaglandin E Receptors in blood mononuclear cells and plaque of patients with carotid atherosclerosis: Regulation by nuclear factor-κB

    Atherosclerosis, Vol. 187, Núm. 1, pp. 139-149

  4. Parthenolide modulates the NF-κB-mediated inflammatory responses in experimental atherosclerosis

    Arteriosclerosis, Thrombosis, and Vascular Biology, Vol. 26, Núm. 8, pp. 1864-1870

2005

  1. Intensive treatment with atorvastatin reduces inflammation in mononuclear cells and human atherosclerotic lesions in one month

    Stroke, Vol. 36, Núm. 8, pp. 1796-1800

2004

  1. NF-κB Activation and Fas Ligand Overexpression in Blood and Plaques of Patients with Carotid Atherosclerosis: Potential Implication in Plaque Instability

    Stroke, Vol. 35, Núm. 2, pp. 458-463

2003

  1. Possible role of parathyroid hormone-related protein as a proinflammatory cytokine in atherosclerosis

    Stroke, Vol. 34, Núm. 7, pp. 1783-1789

  2. Simvastatin reduces NF-κB activity in peripheral mononuclear and in plaque cells of rabbit atheroma more markedly than lipid lowering diet

    Cardiovascular Research, Vol. 57, Núm. 1, pp. 168-177

2001

  1. Atorvastatin reduces Fas and Fas ligand expression in a rabbit experimental model of atherosclerosis

    Investigacion Cardiovascular, Vol. 4, Núm. 1, pp. 15-27